A review of the Cleveland Clinic experience over 26 years has prompted efforts for multi-institutional data pooling to determine whether routine screening is warranted.
A newly published case series bolsters support for the off-label use of flow-diverting stents in this rare condition.
While promising research on anti-inflammatory strategies continues, clinicians can already help patients manage modifiable risk factors for aneurysm formation and rupture.
For this challenging aneurysm type, there’s now a helpful endovascular alternative to surgical management and its attendant morbidity and mortality.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A second flow diverter stent is now commercially available in the U.S. for treating wide-neck intracranial aneurysms. One of its earliest adopters compares and contrasts the two available devices and outlines their place in therapy.
This 19-year-old’s case was marked by significant proximal large vessel tortuosity and extensive prior aortic instrumentation, demanding alternate vascular access with a hybrid approach.